FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2483762904> ?p ?o ?g. }

• W2483762904 endingPage "524" @default.
• W2483762904 startingPage "515" @default.
• W2483762904 abstract "Gastroenteropancreatic neuroendocrine tumors (GEP/NET) are unusual and rare neoplasms that present many clinical challenges. They characteristically synthesize store and secrete a variety of peptides and neuroamines which can lead to the development of distinct clinical syndrome, however many are clinically silent until late presentation with mass effects. Management strategies include surgery cure and cytoreduction with the use of somatostatin analogues. Somatostatin have a broad range of biological actions that include inhibition of exocrine and endocrine secretions, gut motility, cell proliferation, cell survival and angiogenesis. Five somatostatin receptors (SSTR1-SSTR5) have been cloned and characterized. Somatostatin analogues include octreotide and lanreotide are effective medical tools in the treatment and present selectivity for SSTR2 and SSTR5. During treatment is seen disapperance of flushing, normalization of bowel movements and reduction of serotonin and 5-hydroxyindole acetic acid (5-HIAA) secretion. Telotristat represents a novel approach by specifically inhibiting serotonin synthesis and as such, is a promising potential new treatment for patients with carcinoid syndrome. To pancreatic functionig neuroendocrine tumors belongs insulinoma, gastrinoma, glucagonoma and VIP-oma. Medical management in patients with insulinoma include diazoxide which suppresses insulin release. Also mTOR inhibitors may inhibit insulin secretion. Treatment of gastrinoma include both proton pump inhibitors (PPIs) and histamine H2 - receptor antagonists. In patients with glucagonomas hyperglycaemia can be controlled using insulin and oral blood glucose lowering drugs. In malignant glucagonomas smatostatin analogues are effective in controlling necrolytic migratory erythemia. Severe cases of the VIP-oma syndrome require supplementation of fluid losses. Octreotide reduce tumoral VIP secretion and control secretory diarrhoea." @default.
• W2483762904 created "2016-08-23" @default.
• W2483762904 creator A5001596963 @default.
• W2483762904 creator A5004941553 @default.
• W2483762904 creator A5010799497 @default.
• W2483762904 creator A5019040298 @default.
• W2483762904 creator A5040155473 @default.
• W2483762904 creator A5065916792 @default.
• W2483762904 creator A5074750100 @default.
• W2483762904 creator A5075727656 @default.
• W2483762904 creator A5078220236 @default.
• W2483762904 creator A5080556225 @default.
• W2483762904 creator A5088549831 @default.
• W2483762904 date "2017-01-01" @default.
• W2483762904 modified "2023-10-09" @default.
• W2483762904 title "Management of the hormonal syndrome of neuroendocrine tumors" @default.
• W2483762904 cites W131003897 @default.
• W2483762904 cites W1584743295 @default.
• W2483762904 cites W1613677910 @default.
• W2483762904 cites W1785033143 @default.
• W2483762904 cites W1856793168 @default.
• W2483762904 cites W187803284 @default.
• W2483762904 cites W1894791380 @default.
• W2483762904 cites W1942590761 @default.
• W2483762904 cites W1951669519 @default.
• W2483762904 cites W1960988894 @default.
• W2483762904 cites W1968424817 @default.
• W2483762904 cites W1970108520 @default.
• W2483762904 cites W1982061741 @default.
• W2483762904 cites W1982292523 @default.
• W2483762904 cites W1987373615 @default.
• W2483762904 cites W1987953456 @default.
• W2483762904 cites W1996375200 @default.
• W2483762904 cites W1997380178 @default.
• W2483762904 cites W1998880316 @default.
• W2483762904 cites W2001808158 @default.
• W2483762904 cites W2007820973 @default.
• W2483762904 cites W2015631227 @default.
• W2483762904 cites W2019006325 @default.
• W2483762904 cites W2022243114 @default.
• W2483762904 cites W2031301095 @default.
• W2483762904 cites W2034769448 @default.
• W2483762904 cites W2048997600 @default.
• W2483762904 cites W2054627587 @default.
• W2483762904 cites W2056413519 @default.
• W2483762904 cites W2059027605 @default.
• W2483762904 cites W2059777719 @default.
• W2483762904 cites W2060013854 @default.
• W2483762904 cites W2060122062 @default.
• W2483762904 cites W2061192940 @default.
• W2483762904 cites W2065387828 @default.
• W2483762904 cites W2069088347 @default.
• W2483762904 cites W2070502774 @default.
• W2483762904 cites W2071205807 @default.
• W2483762904 cites W2071310612 @default.
• W2483762904 cites W2074339905 @default.
• W2483762904 cites W2076604579 @default.
• W2483762904 cites W2077900583 @default.
• W2483762904 cites W2080369262 @default.
• W2483762904 cites W2080916065 @default.
• W2483762904 cites W2081019043 @default.
• W2483762904 cites W2089678680 @default.
• W2483762904 cites W2090221465 @default.
• W2483762904 cites W2090939912 @default.
• W2483762904 cites W2091760407 @default.
• W2483762904 cites W2092706522 @default.
• W2483762904 cites W2097870417 @default.
• W2483762904 cites W2100283328 @default.
• W2483762904 cites W2107392208 @default.
• W2483762904 cites W2107440795 @default.
• W2483762904 cites W2110922803 @default.
• W2483762904 cites W2111664153 @default.
• W2483762904 cites W2113901744 @default.
• W2483762904 cites W2114647361 @default.
• W2483762904 cites W2119674738 @default.
• W2483762904 cites W2120079194 @default.
• W2483762904 cites W2125332438 @default.
• W2483762904 cites W2127110504 @default.
• W2483762904 cites W2128669850 @default.
• W2483762904 cites W2136817110 @default.
• W2483762904 cites W2137142564 @default.
• W2483762904 cites W2140741951 @default.
• W2483762904 cites W2145243099 @default.
• W2483762904 cites W2147448522 @default.
• W2483762904 cites W2153632959 @default.
• W2483762904 cites W2157744078 @default.
• W2483762904 cites W2160305261 @default.
• W2483762904 cites W2162735572 @default.
• W2483762904 cites W2164614522 @default.
• W2483762904 cites W2166417489 @default.
• W2483762904 cites W2166523330 @default.
• W2483762904 cites W2171460614 @default.
• W2483762904 cites W2189450260 @default.
• W2483762904 cites W2201509363 @default.
• W2483762904 cites W2205368634 @default.
• W2483762904 cites W2209368665 @default.
• W2483762904 cites W2232844861 @default.
• W2483762904 cites W2260411483 @default.

• next